Drugs / NaCl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00464204 Comparator | Jul 2007 → May 2010 | infectious disease with sepsis | Fresenius Kabi | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00464204 ↗ |
| Route | Intravenous | “NaCl 0.9 % was administered intravenously.” NCT00464204 ↗ |